Clairity has concluded a $43m funding round, allowing it to advance commercialisation for its AI-powered breast cancer prediction platform.

Beacon Biosignals has secured $86m in a Series B funding round aimed at expanding its neurodiagnostic dataset and furthering the clinical use of AI-driven brain health biomarkers.

Boston Scientific has entered an agreement with Siemens Healthineers to push forward commercialisation activities for the latter’s AcuNav 4D ICE catheter.

The US FDA has granted 510(k) clearance, expanding the label of BrainsWay’s Deep Transcranial Magnetic Stimulation (TMS) system.

Minze Health has reached an agreement with Medtronic for three years to market the automated bladder diary solution, Minze Diary Pod.

ViTAA Medical’s aortic surgery planning tool has gained clearance from the US Food and Drug Administration (FDA), representing the first milestone in the company’s aim to bring a full spectrum aortic ...

Cornerstone Robotics has raised around $200m in its funding round to expedite commercialisation plans and propel technology advancements.

Owlet has partnered with Rhapsody to integrate data from its at-home pulse oximeter, BabySat, directly into the patient’s EHRs.

From e-health records to a biotech hub in Tartu, Estonia is harnessing data, digital infrastructure, and investment to drive life sciences growth.

The FDA has granted 510(k) clearance to Augmedics’ new augmented reality (AR) headset, X2, designed for use with the xvision Spine System.

Myriad Genetics has broadened the scope of its MyRisk Hereditary Cancer Test for germline testing, adding genes.

A new whitepaper from Alleima explores how guidewire technology is evolving with the growing prevalence of chronic conditions ...